Know Cancer

or
forgot password

Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI: What is the Added Value of Diffusion Weighted Imaging in Diagnosis and Follow-up


N/A
25 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI: What is the Added Value of Diffusion Weighted Imaging in Diagnosis and Follow-up


Inclusion Criteria:



- Patients with clinical and laboratory findings, highly suggestive for multiple
myeloma.

Exclusion Criteria:

- All patients who are not allowed to be scanned on MRI (Pacemaker, implants ed.)

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Validation

Outcome Description:

Validation of whole body MRI diffusion-weighted imaging in multiple myeloma at 3 Tesla MRI: correlation of the new MRI imaging technique (diffusion weighted imaging)to standard validated imaging technique (Computer Tomography and Magnetic Resonance Imaging)

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Steven Pans, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universitaire Ziekenhuizen Leuven

Authority:

Belgium: Federal Agency for Medicinal Products and Health Products

Study ID:

FIMM

NCT ID:

NCT01780766

Start Date:

September 2008

Completion Date:

September 2014

Related Keywords:

  • Multiple Myeloma
  • Whole body MRI
  • Multiple myeloma
  • Diffusion Weighted MRI
  • Whole body scan
  • Body Weight
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location